期刊文献+

真性红细胞增多症和原发性血小板增多症与脑血栓形成 被引量:5

Polycythemia vera and essential thrombocytosis and cerebral thrombosis
原文传递
导出
摘要 真性红细胞增多症(polycythemia vera,PV)和原发性血小板增多症(essential thrombocythemia,ET)是最常见的2种骨髓增生性疾病亚型.近年来的研究显示,脑血栓形成是PV和ET的主要并发症之一,与患者转归不良密切相关.此外,PV和ET也会增高脑血栓形成患者的脑血管事件复发风险.文章对PV和ET与脑血栓形成相关性的研究进展进行了综述,以期为PV和ET的临床防治提供依据. Polycythemia vera(PV)and essential thrombocythemia(ET)are the two most common subtypes of myeloproliferative diseases.Recent studies have shown that cerebral thrombosis is one of the major complications of PV and ET,which is closely related to the poor outcomes of patients.Meanwhile,PV and ET also increase the risk of recurrent cerebrovascular events in patients with cerebral thrombosis.This article reviews the research progress on the correlation between PV and ET and cerebral thrombosis,in order to provide the basis for clinical prevention and treatment of PV and ET.
作者 宋颖 徐佳亮 蔺慕会 陈晓虹 Song Ying;Xu Jialiang;Lin Muhui;Chen Xiaohong(China Medical University,Shenyang 110102,China;Department of Neurology,the People's Hospital of Liaoning Province,Shenyang 110016,China)
出处 《国际脑血管病杂志》 2020年第4期303-308,共6页 International Journal of Cerebrovascular Diseases
基金 辽宁省自然科学基金(20170540528)。
关键词 真性红细胞增多症 血小板增多 原发性 颅内栓塞和血栓形成 静脉血栓形成 危险因素 Polycythemia vera Thrombocythemia essential Intracranial embolism and thrombosis Venous thrombosis Risk factors
  • 相关文献

参考文献4

二级参考文献12

  • 1Baxter EJ,Scott LM,Campbcll PJ’et al.Acquired mutation of thetyrosine kinase JAK2 in human myeloproliferative discascs[J].Lancet, 2005, 365 (9464):1054-61.
  • 2Antonioli E, Guglielmelli P, Poli G , et al.Influenceof JAK.2V617F allele burden on phenotype in essentialthrombocythemia[J].Haematologica,2008,93( 1):41 -8.
  • 3Reikvam H, Tiu RV. Venous thromboembolism in patients withessential thrombocythcmia and polycythemia vera[J]. Leukemia,2012,26(4):563-71.
  • 4Campbell PJ, Scott LM, Buck G, et al. Definition of subtypes ofessential thrombocythaemia and relation to polycythaemia verabased on JAK2 V617F mutation status: a prospective study[J].Lancct,2005,366(9501): 1945-53.
  • 5De Stefano V.Rossi E, Za T,et al.)AK2 V617F mutationalfrequency in essential thrombocythemia associated withsplanchnic or cerebral vein thrombosis[J]. Am J Hematol,2011,86(6):526-8.
  • 6Landolfi R, Di Gcnnaro L, Barbui T, et al. Leukocytosis as a majorthrombotic risk factor in patients with polycythemia vcra[J].Blood,2007,109(6):2446-52.
  • 7Landolfi R,Di Gcnnaro L,Falanga A. Thrombosis inmyeloproliferative disorders: pathogenetic facts andspeculation[J]丄 eukemia,2008,22( 11 ):2020-8.
  • 8Carobbio A,Finazzi G,Gucrini W,et al. Leukocytosia is a riskfactor for thrombosis in essential thrombocythemia: interactionwith treatment, standard risk factors, and JAK2 mutationstatus[J].Blood,2007,109(6):2310-3.
  • 9真性红细胞增多症诊断与治疗中国专家共识(2016年版)[J].中华血液学杂志,2016,37(4):265-268. 被引量:54
  • 10Chao Sun,Xin Zhou,Zhi-Jian Zou,Hong-Feng Guo,Jian-Yong Li,Chun Qiao.Clinical Manifestation of Calreticulin Gene Mutations in Essential Thrombocythemia without Janus Kinase 2 and MPL Mutations: A Chinese Cohort Clinical Study[J].Chinese Medical Journal,2016(15):1778-1783. 被引量:2

共引文献27

同被引文献34

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部